ArticleTrauma case reports2025
Analysis of ECMO usage in trauma patients at a major level 1 trauma center.
Article in Trauma case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Extracorporeal membrane oxygenation improves survival for trauma patients: fact, fiction, or the future?Trauma surgery & acute care open · 2026Article
- Challenges of ECMO use for severe trauma: a narrative review.Hereditas · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracorporeal membrane oxygenation (ECMO) has been used for decades in patients where adequate oxygenation could not be achieved using traditional efforts. Data is emerging regarding its use in trauma. Retrospective data was collected from the ECMO database at an urban Level 1 trauma center between 2020 and 2024. Inclusion data was age > 17 years, trauma, and ECMO utilization during admission. Outcomes extracted included patient demographics, mechanism and type of injury, type of ECMO, ECMO days, hospital length of stay (LOS), intensive care LOS, date of injury to ECMO time, P/F ratio, ISS, complications, co-morbidities, anticoagulation, and mortality. Of the included 24 patients, 23 received veno-venous (VV) ECMO and one veno-arterial (VA) ECMO. The overall group demographics were:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.